address stigma is “Focus on me, not my skin” carried out in 2012 by the Croatian Psoriasis Association. Its purpose was to increase awareness about the everyday challenges of people with psoriasis. Global report on psoriasis 31 26 Box 3. Campaign "Swim for psoriasis" ©EADV. Another example of a campaign for raising awareness of psoriasis is the action "Swim for psoriasis", carried out by the European Academy of Dermatology and Venereology (EADV) in 2014 at the Ixelles swimming pool in Brussels, Belgium. It aimed to fight the prevalent prejudices about psoriasis. Famous Belgians, politicians, dermatologists and patients’ associations came together as #teampsoriasis at the local swimming pool to swim in support of people with psoriasis. Empowering patients Patients' organizations and civil society also have an important role in improving the situation of people with psoriasis. This includes ongoing advocacy on behalf of patients, and government and policy-‐maker monitoring of the progress of the implementation of resolution WHA67.9 on psoriasis and this report's recommendations. The role of patients’ organizations in the creation of peer support groups and social campaigns to increase awareness among society is significant. For other NCDs, patients’ organizations have shown that self-‐care interventions delivered through community action can be complementary to conventional health care or standalone programmes (168). Community support and family involvement are opportunities to strengthen knowledge and self-‐efficacy and to build capacity to deliver self-‐management across a range of chronic diseases. Standardized tools, diagnosis and treatment Health-‐care providers and dermatologists should use standardized tools to assess the severity of psoriasis and the impact of the disease on QoL. It is important that the medical community reaches a consensus on using a standardized classification of psoriasis and uniform tools for its evaluation. This includes developing standard criteria and guidelines for the diagnosis of psoriasis, which have been developed in a number of countries, including, for example, in the United Kingdom of Great Britain and Northern Ireland (148) and South Africa (176). In addition, guidelines on the treatment of psoriasis are required, including clinical protocols that can be implemented realistically in resource-‐poor primary care settings. Increasing the capacity of the health workforce There is a need to increase the skills and capacity of primary health care providers for psoriasis diagnosis and management. Specialist dermatologists are unavailable for the majority of people living with psoriasis, especially in low-‐ and middle-‐income countries. The umbrella organizations of health-‐care providers should take the initiative to conduct education and training for physicians and other health-‐care providers such as nurses and Box 4. Campaign “Swim for psoriasis” ©EADV. Another example of a campaign for raising awareness of psoriasis is the action “Swim for psoriasis”, carried out by the European Academy of Dermatology and Venereology (EADV) in 2014 at the Ixelles swimming pool in Brussels, Belgium. It aimed to fight the prevalent prejudices about psoriasis. Famous Belgians, politicians, dermatologists and patients’ associations came together as #teampsoriasis at the local swimming pool to swim in support of people with psoriasis. Global report on psoriasis 33 Chapter 5. Recommendations In 2014, WHO Member States recognized psoriasis as a serious NCD in resolution WHA67.9. The resolution underscored that too many people in the world suffer needlessly from psoriasis due to incorrect or delayed diagnosis, inadequate treatment options and insufficient access to care. This Global report on psoriasis brings the public health impact of psoriasis into focus. The report helps raise awareness of the variety of ways that psoriasis can impact people’s lives and empowers policy-makers with practical solutions to improve the health care and social inclusion of people in their populations living with this disease. The control of psoriasis and prevention of its